Abstract
In a cross-sectional study of 89 736 adolescents in Kentucky, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination provided an estimated protection against infection of 81% when the highly transmissible Delta variant was predominant. Vaccination provided added benefit to those with a history of prior infection. These findings support the recommendation that all adolescents receive SARS-CoV-2 vaccination.
Keywords: adolescents; infection-derived immunity; reinfection; vaccine-derived immunity.
All Keywords
【저자키워드】 adolescents, Reinfection, vaccine-derived immunity., infection-derived immunity, 【초록키워드】 SARS-CoV-2, coronavirus, vaccination, Immunity, cross-sectional, Infection, delta variant, SARS-CoV-2 vaccination, Support, acute respiratory syndrome, benefit, provided, added, predominant, receive, 【제목키워드】 Test, Delta, coronavirus 2, Adolescent, respiratory, Result,
【저자키워드】 adolescents, Reinfection, vaccine-derived immunity., infection-derived immunity, 【초록키워드】 SARS-CoV-2, coronavirus, vaccination, Immunity, cross-sectional, Infection, delta variant, SARS-CoV-2 vaccination, Support, acute respiratory syndrome, benefit, provided, added, predominant, receive, 【제목키워드】 Test, Delta, coronavirus 2, Adolescent, respiratory, Result,